Professional
Added to YB: 2024-02-06
Pitch date: 2024-02-06
ROIV [bullish]
Roivant Sciences Ltd.
+113.53%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
Market Cap
$14.1B
Pitch Price
$10.35
Price Target
20.00 (-10%)
Dividend
N/A
EV/EBITDA
-9.39
P/E
-20.20
EV/Sales
505.07
Sector
Biotechnology
Category
value
Show full summary:
Tourlite Capital new position - Roivant Capital ($ROIV)
$ROIV: Sum-of-parts upside to $20 target. Cash+IMVT stake-2yr burn = $13/sh floor. Pipeline+litigation claims add $7+/sh. Mgmt aligned, makes small asymmetric bets. Televant deal showcases value creation ability.
Read full article (1 min)